Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors' reply.
Saved in:
| Title: | Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors' reply. |
|---|---|
| Authors: | Rundquist, Sara1 (AUTHOR) sara.rundquist@regionorebrolan.se, Sachs, Michael C.2 (AUTHOR), Eriksson, Carl1,2 (AUTHOR), Olén, Ola2,3 (AUTHOR), Montgomery, Scott2,4 (AUTHOR), Halfvarson, Jonas1 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Mar2021, Vol. 53 Issue 5, p642-643. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 148631641 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors' reply. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Rundquist%2C+Sara%22">Rundquist, Sara</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> sara.rundquist@regionorebrolan.se</i><br /><searchLink fieldCode="AR" term="%22Sachs%2C+Michael+C%2E%22">Sachs, Michael C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eriksson%2C+Carl%22">Eriksson, Carl</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Olén%2C+Ola%22">Olén, Ola</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Montgomery%2C+Scott%22">Montgomery, Scott</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Halfvarson%2C+Jonas%22">Halfvarson, Jonas</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Alimentary+Pharmacology+%26+Therapeutics%22">Alimentary Pharmacology & Therapeutics</searchLink>. Mar2021, Vol. 53 Issue 5, p642-643. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=148631641 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/apt.16241 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: 642 Titles: – TitleFull: Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors' reply. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rundquist, Sara – PersonEntity: Name: NameFull: Sachs, Michael C. – PersonEntity: Name: NameFull: Eriksson, Carl – PersonEntity: Name: NameFull: Olén, Ola – PersonEntity: Name: NameFull: Montgomery, Scott – PersonEntity: Name: NameFull: Halfvarson, Jonas IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2021 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 02692813 Numbering: – Type: volume Value: 53 – Type: issue Value: 5 Titles: – TitleFull: Alimentary Pharmacology & Therapeutics Type: main |
| ResultId | 1 |